Satellos Bioscience Inc.
MSCLF
$0.52
$0.00611.19%
| Weiss Ratings | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.83 | |||
| Price History | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.45% | |||
| 30-Day Total Return | -5.18% | |||
| 60-Day Total Return | -13.96% | |||
| 90-Day Total Return | -7.60% | |||
| Year to Date Total Return | -17.60% | |||
| 1-Year Total Return | 24.94% | |||
| 2-Year Total Return | 18.78% | |||
| 3-Year Total Return | -17.67% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -44.39% | |||
| 52-Week Low % Change | 74.85% | |||
| Price | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.94 | |||
| 52-Week Low Price | $0.30 | |||
| 52-Week Low Price (Date) | May 06, 2024 | |||
| 52-Week High Price (Date) | Dec 11, 2024 | |||
| Valuation | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 82.27M | |||
| Enterprise Value | 33.46M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.18 | |||
| Earnings Per Share Growth | 33.09% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 1.83 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.52 | |||
| Enterprise Value/EBITDA (TTM) | -1.65 | |||
| Enterprise Value/EBIT | -1.65 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 120.50M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | Royal Bank Plaza Toronto, ON M5J 2J1 | |||
| Website | satellos.com | |||
| Country | Canada | |||
| Year Founded | 2018 | |||
| Profitability | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -30.10% | |||
| Return on Equity | -- | |||
| Income Statement | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -14.31M | |||
| EBITDA (TTM) | -20.28M | |||
| EBIT (TTM) | -20.30M | |||
| Net Income (TTM) | -20.53M | |||
| Net Income Avl. to Common (TTM) | -20.53M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 9.19% | |||
| EPS Diluted (TTM) | -0.18 | |||
| EPS Diluted Growth (Q YOY) | 15.02% | |||
| Balance Sheet | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 48.55M | |||
| Cash Per Share (Q) | $0.40 | |||
| Total Current Assets (Q) | 50.74M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 47.16M | |||
| Current Ratio (Q) | 14.164 | |||
| Book Value Per Share (Q) | $0.28 | |||
| Total Assets (Q) | 50.75M | |||
| Total Current Liabilities (Q) | 3.58M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 3.58M | |||
| Total Common Equity (Q) | 47.16M | |||
| Cash Flow | MSCLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 4.84M | |||
| Cash from Financing (TTM) | 38.21M | |||
| Net Change in Cash (TTM) | 25.38M | |||
| Levered Free Cash Flow (TTM) | -11.77M | |||
| Cash from Operations (TTM) | -18.21M | |||
